Dallas, Texas, February 4, 2014 - Rosewood Private Investments ("RPI") is proud to announce the recent acquisition of substantially all of the assets of United I International Laboratories, LLC ("United"). United is RPI's first platform company in the nutritional supplement formulation and manufacturing space. RPI expects to build upon the success and organic growth of United by pursuing add-on acquisitions of complimentary businesses.
Marquez Bela, a Director at RPI, stated, "This transaction is a great opportunity to partner with an exemplary management team and to invest in an industry that we believe can really benefit from institutional capital. With United's great reputation in the marketplace, we can build a substantial industry player."
United I International Laboratories is a marquee name in the nutritional supplement formulation and manufacturing space. Located in Carrollton, TX, United is uniquely positioned to serve customers across the country. Specializing in ingestible liquid and gel manufacturing, United also has capabilities to produce powders and OTC pharmaceuticals, as well as cosmetic lotions and creams. United produces quality products for branded and private label customers in the mass retail, specialty retail and direct selling distribution channels.
Rosewood Private Investments is the private equity arm of The Rosewood Corporation, a family-backed yet institutional firm with diverse worldwide operations and investments. Rosewood is wholly owned by the Caroline Hunt Trust Estate, which was established in 1935 by H.L. Hunt and built upon over generations by developing and acquiring businesses that are leaders in their respective industries. Our structure and history enable us to be a unique resource and flexible investment partner. As an evergreen entity, Rosewood is continually seeking to invest capital in companies that share our commitment to entrepreneurism, integrity, and sound business principles.
Rosewood has a long history investing in and creating value within a number of manufacturing companies and RPI views this investment as a key platform within its Specialty Manufacturing industry vertical focus. RPI has a particular interest in deploying additional capital in the nutritional supplement formulation and manufacturing industry and would welcome any information with regards to potential add-on opportunities.